Copper(II) monohelix complexes with pyrazine-modulated long-chain oligo-α-aminopyridine ligand: synthesis, crystal structures, and bioactivity studies
| dc.contributor.author | Ismayilova, Sabina Zahid | |
| dc.contributor.author | Ismayilov, Rayyat Huseyn | |
| dc.contributor.author | Tagiyev, Dilgam Babir | |
| dc.contributor.author | Senol, Halil | |
| dc.contributor.author | Medjidov, Ajdar Akber | |
| dc.contributor.author | Huseynova, Mansura Teyfur | |
| dc.contributor.author | Yalcin, Bahattin | |
| dc.date.accessioned | 2026-04-25T14:19:58Z | |
| dc.date.available | 2026-04-25T14:19:58Z | |
| dc.date.issued | 2025 | |
| dc.department | Sinop Üniversitesi | |
| dc.description.abstract | Using the pyrazine-modulated pentapyridyltetraamine ligand N-2,N-2 '-(pyridine-2,6-diyl)bis(N-6-(pyrazin-2-yl)pyridine-2,6-diamine) H4N9-2pz, three new mononuclear complexes [Cu(H4N9-2pz)](NO3)(2)center dot(CH3CN) 1, [Cu(H4N9-2pz)]Cl-2 center dot 2(H2O) 2 and [Cu(H3N9-2pz)] (CH3COO)center dot 2.5(H2O) 3 have been synthesized, structurally characterized, and their bioactivity properties studied. In vitro analysis of complexes 1-3 revealed that they inhibited AChE and BChE more effectively than the widely available inhibitor tacrine (IC50: 123.58 +/- 6.80 and 146.18 +/- 7.91 mu M). Additionally, their IC50 values for AChE and BChE ranged from 32.87 to 68.15 and 14.60 to 31.68 mu M, respectively. The g( | |
| dc.description.abstract | ) and g(perpendicular to) components of the g factor have similar values in the EPR spectrum of complexes 1-3 (g( | |
| dc.description.abstract | ) = 2.0179 and g(perpendicular to) = 2.1246 for 1; g( | |
| dc.description.abstract | ) = 2.0044 and g(perpendicular to) = 2.1425 for 2; g( | |
| dc.description.abstract | ) = 2.0118 and g(perpendicular to) = 2.1356 for 3). The single crystal X-ray approach revealed a distorted trigonal bipyramidal geometry of the complexes, which is consistent with the inverted type of EPR spectra (g(perpendicular to) > g( | |
| dc.description.abstract | )similar to ge), measured magnetic moment susceptibility, and electronic spectrum studies. The comparable structures of complexes 1-3 suggest that the H4N9-2pz ligand, rather than the nitrate, carboxylate, or chloride counterions, is critical for complex formation. | |
| dc.identifier.doi | 10.1016/j.molstruc.2025.143295 | |
| dc.identifier.issn | 0022-2860 | |
| dc.identifier.issn | 1872-8014 | |
| dc.identifier.orcid | 0000-0002-8333-035X | |
| dc.identifier.orcid | 0000-0002-3957-7996 | |
| dc.identifier.scopus | 2-s2.0-105010933277 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1016/j.molstruc.2025.143295 | |
| dc.identifier.uri | https://hdl.handle.net/11486/8293 | |
| dc.identifier.volume | 1347 | |
| dc.identifier.wos | WOS:001555985200003 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Journal of Molecular Structure | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20260420 | |
| dc.subject | Modulated oligo-alpha-aminopyridine ligand | |
| dc.subject | Copper complex | |
| dc.subject | Hydrogen bonds | |
| dc.subject | Supramolecular networks | |
| dc.subject | Enzyme inhibition | |
| dc.title | Copper(II) monohelix complexes with pyrazine-modulated long-chain oligo-α-aminopyridine ligand: synthesis, crystal structures, and bioactivity studies | |
| dc.type | Article |












